CIPLA Generic Product List, Medicine List With Price, Distributors, Achievements And Awards PDF Free Download
CIPLA Generic Product List PDF Download
Khawaja Abdul Hameed Established Cipla In 1935 As “the Chemical, Industrial & Pharmaceutical Laboratories” In Mumbai. The Company’s Name Was Changed To “cipla Limited” In July 1984. The Company’s Bulk Drug Against Hiv And Other Medications For The Treatment Of Underprivileged People In Developing Nations Received Fda Approval In 1985. The Company Provides Generic Aids And Other Pharmaceuticals To Treat Underprivileged People In The Developing World Under The Direction Of The Founder’s Son Yusuf Hameed, A Chemist With A Degree From Cambridge.
The First Oral Iron Chelator In History, Deferiprone, Was Introduced By Cipla In 1995. Antiretrovirals For Hiv Treatment Were Made Available By Cipla In 2001 For Less Than $350 Per Patient Annually. The South African Business Cipla-medpro Was Purchased By Cipla In 2013, And Cipla Kept It As A Subsidiary, Renaming It Cipla Medpro South Africa Limited. At The Time Of The Acquisition, Cipla-medpro, The Third-largest Pharmaceutical Company In South Africa, Had Been A Distribution Partner For Cipla.
The Business, Which Went By The Name Enaleni Pharmaceuticals Ltd., Was Established In 2002. Enaleni Acquired All Of The Shares Of Cipla-medpro, A Joint Venture Between Cipla And The South African Generics Company Medpro Pharmaceuticals, In 2005. In 2008, It Changed Its Name To Cipla-medpro. By Collaborating With Wellthy Therapeutics In India And Brandmed In South Africa, Cipla Joined The Digital Therapeutics Market In 2019.
Achievements And Awards
- The Thomson Reuters India Innovation Award Was Given To Cipla In 2012.
- In 2006, Cipla Took Up The Dun & Bradstreet American Express Corporate Award.
- In 2007, Forbes Listed Cipla As One Of The Top 200 “best Under A Billion” Small Asian Businesses.
- Cipla Got The Chemexcil Award For Excellence In Exports In 1980.
- Cipla Placed Third In The List Of India’s Most Reputable Brands (Pharmaceuticals) In 2015, According To A Survey Done By Bluebytes, A Reputable Media Analytics Company, In Collaboration With Tra Research, A Brand Insights Agency (Both A Part Of The Comniscient Group).
CIPLA Product List
ANTI-ALLERGICS
| BRAND NAME | MOLECULE | DOSAGE FORM |
|---|---|---|
| ALERGIN | CETIRIZINE HYDROCHLORIDE IP 10 MG | TABLETS |
| ALERGIN – L | LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG | TABLETS |
| BILACIP TABS | BILASTINE 20 MG | TABLETS |
| BILACIP-M | BILASTINE 20 MG + MONTELUKAST SODIUM IP 10 MG | TABLETS |
| CETCIP | CETRIZINE HYDROCHLORIDE IP 10 MG | TABLETS |
| CETCIP – L | LEVOCETIRIZINE HYDROCHLORIDE IP 5MG | TABLETS |
| CETCIP 30 ML | CETRIZINE HCL BP 5 MG/5 ML | SYRUP |
| EMIN | PROMETHAZINE THEOCLATE IP 25 MG | TABLETS |
| FEXIGRA 120 TABS | FEXOFENADINE HYDROCHLORIDE IP 120 MG | TABLETS |
| FEXIGRA 180 TABS | FEXOFENADINE HYDROCHLORIDE IP 180 MG | TABLETS |
| LORATIN | LORATADINE IP 10 MG | TABLETS |
| MONTECIP LC TABS | MONTELUKAST SODIUM IP 10 MG + LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG | TABLETS |
| NEW OKACET | CETIRIZINE 10 MG | TABLETS |
| OKACET 10 MG | CETRIZINE HYDROCHLORIDE IP 10 MG | TABLETS |
| OKACET – L | LEVOCETIRIZINE HYDROCHLORIDE IP 5MG | TABLETS |
| OKACET – L 30ML | LEVOCETIRIZINE DIHYDROCHLORIDE 2.5 MG | SYRUP |
| OKACET SYRUP | CETRIZINE HCL IP 5 MG / 5 ML | SYRUP |
| VERTIRON | CINNARIZINE IP 25 MG | TABLETS |
ANTI-ASTHMATIC
| BRAND NAME | MOLECULE | DOSAGE FORM |
|---|---|---|
| DERICIP | THEOPHYLLINE IP 23 MG + ETOPHYLLINE 77 MG | TABLETS |
| DERICIP 150 RETARD | ETOFHYLINE IP 115 MG + THEOPHYLLINE IP 35 MG | TABLETS |
| DERICIP 300 RETARD | ETOPHYLLINE 231 MG + THEOPHYLLINE IP 69 MG | TABLETS |
| DOXOCIP | DOXOFYLLINE 400 mg + EXCIPIENTS Q.S. | TABLETS |
ANTIBIOTICS
| BRA)ND NAME | MOLECULE | DOSAGE FORM |
|---|---|---|
| AZICIP 100 | AZITHROMYCIN 100 MG | SUSPENSION |
| AZICIP 100 ORAL SUSPN | AZITHROMYCIN 100 MG PER 5 ML | SUSPENSION |
| AZICIP 200 | AZITHROMYCIN 200 MG | SUSPENSION |
| AZICIP 200 ORAL SUSPN | AZITHROMYCIN 200 MG PER 5 ML | SUSPENSION |
| AZICIP 250 | AZITHROMYCIN 250 MG | TABLETS |
| AZICIP 500 | AZITHROMYCIN 500 MG | TABLETS |
| AZIPRO 250 | AZITHROMYCIN 250 MG | TABLETS |
| AZIPRO 500 | AZITHROMYCIN 500 MG | TABLETS |
| AZOMYCIN 100 | AZITHROMYCIN 100 MG | SUSPENSION |
| AZOMYCIN 100 ORAL SUSPN | AZITHROMYCIN 100 MG PER 5 ML | SUSPENSION |
| AZOMYCIN 200 | AZITHROMYCIN 200 MG | SUSPENSION |
| AZOMYCIN 200 ORAL SUSPN | AZITHROMYCIN 200 MG PER 5 ML | SUSPENSION |
| AZOMYCIN 250 | AZITHROMYCIN 250 MG | TABLETS |
| AZOMYCIN 500 | AZITHROMYCIN 500 MG | TABLETS |
ANTI-DIABETIC
| BRAND NAME | MOLECULE | DOSAGE FORM |
|---|---|---|
| GLIMDA- MV 1 | METFORMIN HYDROCHLORIDE 500MG + GLIMEPIRIDE 1MG + VOGLIBOSE 0.2MG | TABLETS |
| GLIMDA- MV 2 | METFORMIN HYDROCHLORIDE 500MG + GLIMEPIRIDE 2MG + VOGLIBOSE 0.2MG | TABLETS |
| GLINIL | GLIBENCLAMIDE 5MG | TABLETS |
| GLINIL M | GLIBENCLAMIDE IP 5MG + METFORMIN HCL 500MG | TABLETS |
| GLYGARD | GLICLAZIDE 80MG + EXCIPIENTS Q.S. | TABLETS |
| GLYGARD M | GLICLAZIDE 80MG + METFORMIN HYDROCHLORIDE 500MG + EXCIPIENTS Q.S. | TABLETS |
| METFOR 500 | METFORMIN HYDROCHLORIDE IP 500MG | TABLETS |
| OKAMET 500 | METFORMIN HYDROCHLORIDE IP 500MG | TABLETS |
| OKAMET 500 SR | METFORMIN HYDROCHLORIDE IP 500 MG (AS PROLONGED RELEASED) | TABLETS |
| OKAMET GM 501 TABS | METFORMIN HYDROCHLORIDE IP 500 MG (AS PROLONGED RELEASED) + GLIMEPIRIDE IP 1 MG | TABLETS |
| OKAMET GM 502 TABS | METFORMIN HYDROCHLORIDE IP 500 MG (AS PROLONGED RELEASED) + GLIMEPIRIDE IP 2 MG | TABLETS |
| OKAMET GMP 1 TABS | PIOGLITAZONE 15MG + METFORMIN HYDROCHLORIDE IP 500MG (SR) + GLIMEPIRIDE IP 1 MG | TABLETS |
| OKAMET GMP 2 TABS | PIOGLITAZONE 15MG + METFORMIN HYDROCHLORIDE IP 500MG (SR) + GLIMEPIRIDE IP 2 MG | TABLETS |